GlassScriptPhysician profile
Steven J Mccarthy
NPI 1619383874
$2,472.79
in general payments reported to CMS, 2019-2025
12 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $793 · 2020: $361 · 2021: $291 · 2022: $170 · 2023: $621 · 2024: $72.73 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $857.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $857.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,559.28 | 2019-2025 | Anchorage, Augment Injectable, Easyfuse |
| Imperative Care, INC | $290.24 | 2023 | Prodigy Catheter |
| Smith+Nephew, INC. | $265.40 | 2019-2024 | Collagenase Santyl, Regranex |
| Truvic Medical, INC. | $133.49 | 2022 | |
| Lundbeck LLC | $65.23 | 2019-2020 | |
| Misonix INC | $63.09 | 2021 | |
| Treace Medical Concepts, INC. | $18.77 | 2022 | |
| Wright Medical Technology, INC. | $18.66 | 2019 | |
| Organogenesis INC. | $18.49 | 2020 | |
| Osiris Therapeutics INC. | $16.65 | 2019 | |
| Paratek Pharmaceuticals, INC. | $14.00 | 2024 | Nuzyra |
| Janssen Pharmaceuticals, INC | $9.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Mccarthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.